Current treatment of onychomycosis

Indian Journal of Dermatology, Venereology and Leprology

Volumn 73, Issue 6, 2007, Pages 373-376

  Thappa, Devinder ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMOROLFINE; CICLOPIROX; FLUCONAZOLE; GRISEOFULVIN; IMIDAZOLE; ITRACONAZOLE; KETOCONAZOLE; TERBINAFINE; TIOCONAZOLE;

DRUG EFFICACY; DRUG TOLERANCE; EDITORIAL; FINGER NAIL; HUMAN; LIVER TOXICITY; MONOTHERAPY; ONCHOCERCIASIS; ONYCHOMYCOSIS; TOENAIL ONYCHOMYCOSIS; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 36448974564     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: 10.4103/0378-6323.37052     Document Type: Editorial

References (36)

1. Rodgers P, Bassler M. Treating onychomycosis. Am Fam Physician 2001;63:663-72,677-8.
2. rd ed. Elsevier Saunders: China; 2005. p. 123-31.
3. Gupta AK, Ryder JE, Baran R. The use of topical therapies to treat onychomycosis. Dermatol Clin 2003;21:481-9.
4. Roberts DT, Taylor WD, Boyle J; British Association of Dermatologists. Guidelines for treatment of onychomycosis. Br J Dermatol 2003;148:402-10.
5. Zaug M, Bergstraesser M. Amorolfine in onychomycosis and dermatomycosis. Clin Exp Dermatol 1992;17:61-70.
6. Hay RJ, MacKie RM, Clayton YM. Tioconazole nail solution: An open study of its efficacy in onychomycosis. Clin Exp Dermatol 1985;10:111-5.
7. Finnen MJ, Hennessy A, McLean S, Bisset Y, Mitchell R, Megson IL, et al. Topical application of acidified nitrite to the nail renders it antifungal and causes nitrosation of cysteine groups in the nail plate. Br J Dermatol 2007;157:494-500.
8. nd ed. Mosby Elsevier: China; 2006. p. 651-3.
9. th ed. New Delhi: Lippincott Williams and Wilkins 2007. p. 83-93.
10. Roberts DT. Oral terbinafine (Lamisil) in the treatment of fungal infections of the skin and nails. Dermatology 1997;194:37-9.
11. Katz HI, Gupta AK. Oral antifungal drug interactions. Dermatol Clin 1997;15:535-44.
12. Del Rosso JQ, Gupta AK. Oral antifungal agents: Recognition and management of adverse reactions. Todays Ther Trends 1997;15:75-84.
13. Gupta AK, Ryder JE. The use of oral antifungal agents to treat onychomycosis. Dermatol Clin 2003;21:469-79.
14. Gupta AK, De Doncker P, Scher RK, Haneke E, Daniel CR 3rd, Andre J, et al. Itraconazole for the treatment of onychomycosis. Int J Dermatol 1998;37:303-8.
15. Hofmann H, Brautigam M, Weidinger G, Zaun H. Treatment of toenail onychomycosis: A randomized, double-blind study with terbinafine and griseofulvin. LAGOS II Study Group. Arch Dermatol 1995;131:919-22.
16. Goodfield MJ, Andrew L, Evans EG. Short term treatment of dermatophyte onychomycosis with terbinafine. BMJ 1992;304:1151-4.
17. Trepanier EF, Amsden GW. Current issues in onychomycosis. Ann Pharmacother 1998;32:204-14.
18. Doncker PD, Gupta AK, Marynissen G, Stoffels P, Heremans A. Itraconazole pulse therapy for onychomycosis and dermatomycosis: An overview. J Am Acad Dermatol 1997;37:969-74.
19. Havu V, Brandt D, Heikkila H, Hollmen A, Oksman R, Rantanen T, et al. A double-blind, randomised study comparing itraconazole pulse therapy with continuous dosing for the treatment of toenail onychomycosis. Br J Dermatol 1997;136:230-4.
20. De Doncker P, Decroix J, Pierard GE, Roelant D, Woestenborghs R, Jacqmin P, et al. Antifungal pulse therapy for onychomycosis: A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole. Arch Dermatol 1996;132:34-41.
21. Scher RK. Onychomycosis: Therapeutic update. J Am Acad Dermatol 1999;40:S21-6.
22. Gupta AK, Scher RK, Rich P. Fluconazole for the treatment of onychomycosis:an update. Int J Dermatol 1998;37:815-20.
23. Scher RK, Breneman D, Rich P, Savin RC, Feingold DS, Konnikov N, et al. Once-weekly fluconazole (150, 300 or 450 mg) in the treatment of distal subungual onychomycosis of the toenail. J Am Acad Dermatol 1998;38:S77-86.
24. Ling MR, Swinyer LJ, Jarratt MT, Falo L, Monroe EW, Tharp M, et al. Once-weekly fluconazole (450 mg) for 4, 6 or 9 months of treatment for distal subungual onychomycosis of the toenail. J Am Acad Dermatol 1998;38:S95-102.
25. Drake L, Babel D, Stewart DM, Rich P, Ling MR, Breneman D, et al. Once-weekly fluconazole (150, 300 or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail. J Am Acad Dermatol 1998;38:S87-94.
26. Tosti A, Piraccini BM, Lorenzi S, Iorizzo M. Treatment of nondermatphyte mold and Candida onychomycosis. Dermatol Clin 2003;21:491-7.
27. Tosti A, Piraccini BM, Iorizzo M. Management of onychomycosis in children. Dermatol Clin 2003;21:507-9.
28. Gupta AK, Lynde CW, Konnikov N. Single blind randomized study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis. J Am Acad Dermatol 2001;44:485-91.
29. Gupta AK, Baran R, Summerbell R. Onychomycosis: Strategies to improve efficacy and reduce recurrence. J Eur Acad Dermatol Venereol 2002;16:579-86.
30. Gupta AK, Ryder JE. How to improve cure rates for the management of onychomycosis. Dermatol Clin 2003;21:499-505.
31. Gupta AK, Daniel CR. Onychomycosis: Strategies to reduce failure and recurrence. Cutis 1998;62:189-91.
32. Gupta AK, Konnikov N, Lynde CW. Single-blind, prospective study evaluating the efficacy and safety of terbinafine and itraconazole for the treatment of dermatophyte toenail onychomycosis in the elderly. J Am Acad Dermatol 2000;44:479-84.
33. Roberts DT, Evans EG. Subungual dermatophytoma complicating dermatophyte onychomycosis. Br J Dermatol 1998;138:189-90.
34. Baran R, Hay RJ. Partial surgical avulsion of the nail in onychomycosis. Clin Exp Dermatol 1985;10:413-8.
35. Piérard GE, Piérard-Franchimont C, Arrese JE. The boosted antifungal topical treatment (BATT) for onychomycosis. Med Mycol 2000;38:391-2.
36. Piérard GE, Piérard-Franchimont C, Arrese JE. The boosted oral antifungal topical treatment for onychomycosis beyond the regular itraconazole pulse dosing regimen. Dermatology 2000;200:185-7.